Intuitive Surgical will benefit as the need grows for procedures using its robotic devices. DexCom provides critical devices to the increasing population of diabetes patients.
Abbott and DexCom depend heavily on continuous glucose monitoring (CGM) device sales. Vertex is developing therapies that could cure type 1 diabetes.

The 3 Best MedTech Stocks to Buy Now: May 2024

02:30pm, Wednesday, 29'th May 2024
In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity

Dexcom Announces Upcoming Conference Presentation

08:30am, Wednesday, 29'th May 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the William B
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is
OpenAI has recently released its GPT-4o AI bot, touted as a more advanced version of its previous language models. This new bot is more focused on voice inputs and usefulness in day-to-day living t
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM d
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Given its better prospects, we believe DexCom stock (NASDAQ NASDAQ : DXCM) is a better pick than 3M stock (NYSE: MMM). Although these companies are from different sectors, we compare them because of t
Dexcom is a buy despite a recent slowdown in US sales. The upcoming launch of Stelo, a glucose monitor for non-insulin users, has a large potential market and is expected. Ex-US growth remains strong
Moderna has a deep pipeline that should help it land brand-new approvals regularly. DexCom has a massive opportunity in the vast continuous glucose monitoring market.
DexCom shares took a slight tumble after earnings were announced Thursday evening off of strong results. Guidance for the year was upgraded due to growing demand and FDA clearance for the Apple Watch
IoT's benefit lies in its capacity to enhance convenience, efficiency and safety across various domains. IoT enables real-time monitoring and data exchange by connecting everyday objects to the intern
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE